CAS 1346604-75-8

DidesMethyl AlMotriptan-d4

Description:

DidesMethyl AlMotriptan-d4, with the CAS number 1346604-75-8, is a deuterated analog of Almotriptan, a medication primarily used for the treatment of migraine headaches. As a deuterated compound, it contains deuterium, a stable isotope of hydrogen, which can enhance the stability and metabolic profile of the molecule. This modification is often utilized in pharmacokinetic studies to trace the compound's behavior in biological systems. The characteristics of DidesMethyl AlMotriptan-d4 include its role as a selective agonist for serotonin receptors, particularly the 5-HT_1B and 5-HT_1D subtypes, which are implicated in the vasoconstriction of cranial blood vessels and the alleviation of migraine symptoms. The presence of deuterium may also influence its solubility, bioavailability, and overall pharmacological activity compared to its non-deuterated counterpart. As with many pharmaceutical compounds, its safety, efficacy, and specific interactions would be determined through rigorous clinical testing and research.

Formula: C₁₅H₂₁N₃O₂S

Synonyms:

• 1,1,2,2-tetradeuterio-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine
• DidesMethyl AlMotriptan-d4
• 5-[(1-Pyrrolidinylsulfonyl)Methyl]-1H-indole-3-ethanaMine-d4
• 1-[[3-(2-AMinoethyl)-5-indolyl]Methanesulfonyl]pyrrolidine-d4
• 1-[[[3-(2-AMinoethyl)-1H-indol-5-yl]Methyl]sulfonyl]pyrrolidine-d4

Didesmethyl Almotriptan-d4

Controlled Product

CAS: 1346604-75-8

Formula: C₁₅D₄H₁₇N₃O₂S

Color and Shape: Neat

Molecular weight: 311.436

Ref: TR-D440832